vs

Side-by-side financial comparison of Carter Bankshares, Inc. (CARE) and INTEST CORP (INTT). Click either name above to swap in a different company.

Carter Bankshares, Inc. is the larger business by last-quarter revenue ($39.8M vs $32.8M, roughly 1.2× INTEST CORP). On growth, Carter Bankshares, Inc. posted the faster year-over-year revenue change (15.4% vs -10.3%). Carter Bankshares, Inc. produced more free cash flow last quarter ($31.8M vs $-1.6M). Over the past eight quarters, Carter Bankshares, Inc.'s revenue compounded faster (9.1% CAGR vs 4.9%).

Carter Bankshares, Inc. is a U.S. regional bank holding company operating Carter Bank & Trust, a community-focused financial institution. It offers a full range of retail and commercial banking products including deposit accounts, personal and business loans, and wealth management services, primarily serving consumers and small business clients across Virginia and North Carolina.

INTTEST Corp designs, manufactures and distributes precision test and process control solutions for the global semiconductor manufacturing ecosystem. Its offerings include thermal management systems, test interface hardware, and wafer handling tools, serving semiconductor fabs, chip design firms, and automotive and industrial electronics end segments.

CARE vs INTT — Head-to-Head

Bigger by revenue
CARE
CARE
1.2× larger
CARE
$39.8M
$32.8M
INTT
Growing faster (revenue YoY)
CARE
CARE
+25.7% gap
CARE
15.4%
-10.3%
INTT
More free cash flow
CARE
CARE
$33.4M more FCF
CARE
$31.8M
$-1.6M
INTT
Faster 2-yr revenue CAGR
CARE
CARE
Annualised
CARE
9.1%
4.9%
INTT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CARE
CARE
INTT
INTT
Revenue
$39.8M
$32.8M
Net Profit
$1.2M
Gross Margin
45.4%
Operating Margin
27.8%
3.9%
Net Margin
3.8%
Revenue YoY
15.4%
-10.3%
Net Profit YoY
-17.4%
EPS (diluted)
$0.38
$0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CARE
CARE
INTT
INTT
Q4 25
$39.8M
$32.8M
Q3 25
$39.1M
$26.2M
Q2 25
$37.3M
$28.1M
Q1 25
$37.0M
$26.6M
Q4 24
$34.5M
$36.6M
Q3 24
$34.2M
$30.3M
Q2 24
$33.6M
$34.0M
Q1 24
$33.5M
$29.8M
Net Profit
CARE
CARE
INTT
INTT
Q4 25
$1.2M
Q3 25
$5.4M
$-938.0K
Q2 25
$8.5M
$-503.0K
Q1 25
$9.0M
$-2.3M
Q4 24
$1.5M
Q3 24
$5.6M
$495.0K
Q2 24
$4.8M
$230.0K
Q1 24
$5.8M
$662.0K
Gross Margin
CARE
CARE
INTT
INTT
Q4 25
45.4%
Q3 25
41.9%
Q2 25
42.6%
Q1 25
41.5%
Q4 24
39.7%
Q3 24
46.3%
Q2 24
40.6%
Q1 24
43.8%
Operating Margin
CARE
CARE
INTT
INTT
Q4 25
27.8%
3.9%
Q3 25
18.3%
-4.5%
Q2 25
28.5%
-3.3%
Q1 25
30.1%
-10.8%
Q4 24
31.0%
5.7%
Q3 24
20.5%
1.6%
Q2 24
17.6%
1.0%
Q1 24
21.6%
1.6%
Net Margin
CARE
CARE
INTT
INTT
Q4 25
3.8%
Q3 25
13.9%
-3.6%
Q2 25
22.8%
-1.8%
Q1 25
24.2%
-8.7%
Q4 24
4.1%
Q3 24
16.4%
1.6%
Q2 24
14.3%
0.7%
Q1 24
17.4%
2.2%
EPS (diluted)
CARE
CARE
INTT
INTT
Q4 25
$0.38
$0.10
Q3 25
$0.24
$-0.08
Q2 25
$0.37
$-0.04
Q1 25
$0.39
$-0.19
Q4 24
$0.36
$0.13
Q3 24
$0.24
$0.04
Q2 24
$0.21
$0.02
Q1 24
$0.25
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CARE
CARE
INTT
INTT
Cash + ST InvestmentsLiquidity on hand
$14.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$419.7M
$103.6M
Total Assets
$4.9B
$151.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CARE
CARE
INTT
INTT
Q4 25
$14.2M
Q3 25
$16.2M
Q2 25
$19.2M
Q1 25
$22.0M
Q4 24
$19.8M
Q3 24
$18.0M
Q2 24
$20.4M
Q1 24
$27.3M
Total Debt
CARE
CARE
INTT
INTT
Q4 25
Q3 25
$4.9M
Q2 25
$5.9M
Q1 25
$6.9M
Q4 24
$7.9M
Q3 24
$9.0M
Q2 24
$10.0M
Q1 24
$11.0M
Stockholders' Equity
CARE
CARE
INTT
INTT
Q4 25
$419.7M
$103.6M
Q3 25
$412.8M
$101.9M
Q2 25
$405.6M
$102.6M
Q1 25
$401.8M
$99.4M
Q4 24
$384.3M
$99.8M
Q3 24
$386.8M
$100.4M
Q2 24
$364.4M
$99.5M
Q1 24
$359.1M
$99.3M
Total Assets
CARE
CARE
INTT
INTT
Q4 25
$4.9B
$151.3M
Q3 25
$4.8B
$148.3M
Q2 25
$4.8B
$149.7M
Q1 25
$4.7B
$148.0M
Q4 24
$4.7B
$152.3M
Q3 24
$4.6B
$158.4M
Q2 24
$4.5B
$160.6M
Q1 24
$4.6B
$159.5M
Debt / Equity
CARE
CARE
INTT
INTT
Q4 25
Q3 25
0.05×
Q2 25
0.06×
Q1 25
0.07×
Q4 24
0.08×
Q3 24
0.09×
Q2 24
0.10×
Q1 24
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CARE
CARE
INTT
INTT
Operating Cash FlowLast quarter
$39.9M
$-1.0M
Free Cash FlowOCF − Capex
$31.8M
$-1.6M
FCF MarginFCF / Revenue
79.9%
-4.7%
Capex IntensityCapex / Revenue
20.2%
1.6%
Cash ConversionOCF / Net Profit
-0.82×
TTM Free Cash FlowTrailing 4 quarters
$54.6M
$5.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CARE
CARE
INTT
INTT
Q4 25
$39.9M
$-1.0M
Q3 25
$11.8M
$3.5M
Q2 25
$9.6M
$-688.0K
Q1 25
$6.4M
$5.5M
Q4 24
$36.9M
$2.6M
Q3 24
$10.3M
$4.2M
Q2 24
$-2.5M
$-5.1M
Q1 24
$17.6M
$2.1M
Free Cash Flow
CARE
CARE
INTT
INTT
Q4 25
$31.8M
$-1.6M
Q3 25
$10.3M
$3.1M
Q2 25
$7.7M
$-1.1M
Q1 25
$4.9M
$5.3M
Q4 24
$28.8M
$2.4M
Q3 24
$8.4M
$3.7M
Q2 24
$-4.3M
$-5.4M
Q1 24
$16.3M
$1.7M
FCF Margin
CARE
CARE
INTT
INTT
Q4 25
79.9%
-4.7%
Q3 25
26.3%
11.8%
Q2 25
20.6%
-4.1%
Q1 25
13.1%
19.9%
Q4 24
83.5%
6.6%
Q3 24
24.6%
12.4%
Q2 24
-12.7%
-15.9%
Q1 24
48.8%
5.8%
Capex Intensity
CARE
CARE
INTT
INTT
Q4 25
20.2%
1.6%
Q3 25
3.9%
1.6%
Q2 25
5.1%
1.6%
Q1 25
4.1%
0.9%
Q4 24
23.6%
0.4%
Q3 24
5.5%
1.7%
Q2 24
5.4%
0.9%
Q1 24
3.9%
1.1%
Cash Conversion
CARE
CARE
INTT
INTT
Q4 25
-0.82×
Q3 25
2.18×
Q2 25
1.13×
Q1 25
0.71×
Q4 24
1.72×
Q3 24
1.83×
8.58×
Q2 24
-0.51×
-22.13×
Q1 24
3.03×
3.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CARE
CARE

Segment breakdown not available.

INTT
INTT

Environmental Technologies$8.3M25%
Semiconductor Market$6.9M21%
Thermal Testing Products$6.4M19%
Service And Other Products$4.8M15%
Oem Integrators And Distributor$3.5M11%
Semiconductor Production Test Products$3.0M9%

Related Comparisons